Delivery Order 75F40121D00021-75F40122F19010

<p>The Food and Drug Administration issued a delivery order to Biomerieux Inc. on November 22, 2021, with a ceiling value of $1,386.10 for Biomerieux consumables.</p> <p>Place of performance is Calverton, MD. The order was priced on a firm fixed-price basis with an ultimate completion date of December 1, 2021. No set-aside was used.</p>

<p>The Food and Drug Administration issued an $11,016 delivery order to Biomerieux Inc. on November 4, 2021, for Biomerieux consumables. Place of performance is Calverton, MD. The order carries a firm fixed-price structure and an ultimate completion date of December 6, 2021. No set-aside was used.</p>

The Food and Drug Administration issued a $31,522.46 delivery order to Biomerieux Inc. on November 4, 2021, for biomerieux consumables, with an ultimate completion date of July 12, 2022. Place of performance is Calverton, MD. The order is priced on a firm fixed-price basis and carries no set-aside designation. Subcontractors on the order include Lanevis, L.L.C. (an 8(a) program participant), Vergys LLC, Schaffer Consulting LLC, Agisol LLC (an 8(a) program participant and EDWOSB), and Enthalpy...

<p>The Food and Drug Administration issued a delivery order to Biomerieux Inc. on April 27, 2022, with a ceiling value of $11,642.56 for Biomerieux supplies on a firm fixed-price basis. Place of performance is Calverton, MD. The order completed on September 30, 2022.</p>

<p>The Food and Drug Administration issued a delivery order to Biomerieux Inc. on February 8, 2022, with a ceiling value of $10,038.14 under the Biomerieux IDIQ contract for diagnostic equipment or reagents.</p> <p>Place of performance is Calverton, MD. The order carries firm fixed-price pricing and was issued without a set-aside. The ultimate completion date is June 8, 2022.</p>

The Food and Drug Administration issued a $12,218.83 delivery order to Biomerieux Inc. on November 19, 2021, for biomerieux consumables, with an ultimate completion date of December 8, 2021. Place of performance is Calverton, MD. The order carries a firm fixed-price pricing structure and no set-aside designation. Biomerieux Inc. operates through its Vitek Systems division as a specialized supplier of in vitro diagnostic consumables, reagents, and microbiological testing solutions to federal...

<p>The Food and Drug Administration issued a $20,940.38 delivery order to Biomerieux Inc. on May 18, 2022, for supplies with a completion date of September 30, 2022. Place of performance is Calverton, MD. The order is priced on a firm fixed-price basis with no set-aside applied.</p>

<p>The Food and Drug Administration issued a delivery order to Biomerieux Inc. on April 6, 2026, with a ceiling value of $21,662.16 for three deliveries under the FDA/NYHAFL Biomerieux IDIQ contract. Place of performance is Irvine, CA. The order carries firm fixed-price pricing and an ultimate completion date of July 28, 2026. No set-aside was used.</p>

The Food and Drug Administration issued a delivery order to Biomerieux Inc. on January 12, 2024, with a ceiling value of $42,935.88 under a firm fixed-price arrangement. Place of performance is Irvine, CA. The order carries no set-aside designation and has an ultimate completion date of August 30, 2024. Biomerieux Inc. operates through its Vitek Systems division and supplies in vitro diagnostic equipment, reagents, and test kits for microbiological testing and infectious disease detection to...

<p>The Food and Drug Administration issued a delivery order to Biomerieux Inc. on March 23, 2026, under the FDA/NYHAFL Biomerieux IDIQ contract with a ceiling value of $44,605.92 for three deliveries of diagnostic equipment and reagents.</p> <p>Place of performance is Jamaica, NY. The order is firm fixed price with an ultimate completion date of August 3, 2026. No set-aside was used.</p>